CSIC Technologies Catalogue 2026(PDF) Available Technological Offer Search Technological category - Any - Agriculture, livestock and marine science Aquaculture Agrotechnology Biocontrol Biostimulant Crop improvement Fishery Animal production Animal health Forestry Technology Plant variety Biotechnology Biocatalyst Molecular and cell biology Biomaterial Bioprocess Biochemistry Biosensor Plant biotechnology Genetic engineering Electronics Chips / Circuits / Micro & nanoelectronics Detection / Sensing (electronics) Robotics / Automation Energy Energy Storage Thermal storage Batteries Supercapacitors Carbon capture Nuclear energy Fossil energy source Coal and hydrocarbons Mining and extraction Renewable energy source Biofuel / Synthetic fuel Biomass Wind energy Photovoltaics Solar / Thermal energy Energy Production Hydrogen Fuel cells Humanities and Social Sciences Art Cultural industries Heritage Public policies /Social innovation Language technologies Materials Catalyst Ceramics Composite Graphene Instrumentation Construction Printing Measurement /sensing (materials) Coating Smart / Functional material Sustainable material Metals and alloys Micro & Nanomaterial Carbon nanotube Plastic / Polymer Plásticos y polímeros Chemicals Semiconductor Textile Environment Air pollution and treatment Water pollution and treatment Waste management Measurement / Quality control Prediction models Recycling / Recovery Chemistry Chemical analysis Industrial Process Chemical Synthesis Separation techniques Health Clinical Application Cardiovascular Dermatology Orphan and Rare Disease Infectious disease Inflammatory disease Respiratory disease Gastroenterology Haematology / Blood disorder Immunology Metabolism (diabetes, obesity, endocrinology) Nephrology Neurology Ophthalmology Oncology Ear, nose & throat Other (therapeutics) Mental health Musculoskeletal disorder Cosmetics Diagnostics Biomarker Imaging Microarray Sensor Medical device Detection Imaging Implantable / Pprosthetic Surgical Treatment Research tools Screening assay Cell line Labelling Animal Model Reagent Expression system Vector & plasmids Therapy Drug delivery DNA / RNA Antibodies Bacteria Target Small Molecule Peptide / Protein Cell Therapy Gene Therapy Vaccine Food technology Food quality and safety Ingredients / Functional food Food processing ICT Bioinformatics Cybersecurity Communication Artificial Intelligence Machine Learning Robotics IoT Data Mining Apply Reset Health Diagnostics Imaging Therapy Drug delivery Oncology Engineered gold nanoparticles for enhanced radiotherapy Engineered gold-containing mesoporous silica nanoparticles act as next-generation radioenhancers for cancer radiotherapy. The platform enhances tumour-specific radiation effects while improving nanoparticle biocompatibility, circulation time and tumour acumulation. Health Diagnostics Imaging Oncology Fluorescent nanovesicles as a bioimaging tool Ultra-bright fluorescent nanoparticles with Near-Infrared emission for non-invasive imaging and diagnostics. Health Therapy Small Molecule Oncology CCTBloCk, repurposed drugs as breast cancer therapy Two repurposed drugs have been identified that act by inhibiting CCT, an essential chaperone in tumor proteostasis and the folding of key proteins for tumor proliferation, migration, and invasiveness. Health Therapy Cell Therapy Oncology Copper–Thiourea Anticancer Complexes with Enhanced Potency and Reduced Toxicity Copper complexes with thiourea ligands have demonstrated high cytotoxic activity against tumor cells, along with low toxicity in murine models. Furthermore, these complexes exhibit high stability under physiological conditions. Health Therapy Oncology Process for increasing the efficiency of magnetic iron oxide nanoparticles in hyperthermia New method that enhances the performance of iron oxide nanoparticles (IONPs), facilitating the implementation of magnetic hyperthermia (MH) therapies. Health Clinical Application Therapy Oncology In vivo verification of radiation dose delivered in particle therapies System that enables the measurement and verification of the radiation dose received by a patient following proton or helium ion therapy. It uses PET and the natural production of F-18 in tissues, offering applications in oncology and clinical safety. Health Therapy Peptide / Protein Oncology Agriculture, livestock and marine science Legume derived nutraceuticals as radiosensitizing agents for tumor cells Natural nutraceutical to promote the prevention of the cancer stem cells (CSCs) phenotype acquisition at the origin of tumor regrowth, metastasis and relapse. Health Medical device Therapy Materials Micro & Nanomaterial Health Oncology Hydrogel for its use in CAR-T Therapy Novel Hydrogel with optimized mechanical and structural properties to resemble artificial lymph nodes and improve primary human CAR-T cell manufacture. Health Therapy Small Molecule Oncology Novel type of PROTACs directly targeting the proteasome for cancer treatment Design of a novel proteolytic set of chimeras (26STACs) directed at the degradation of the ceramide transfer protein CERT-1 by the proteasome, in an E3-independent manner, for its use in the treatment of breast cancer. Health Therapy Peptide / Protein Oncology Mactide-V, a peptide-drug-conjugate for efficient treatment of triple-negative breast cancer Effective triple-negative breast cancer treatment based on the modulation of the phenotype of CD206+ tumor associated macrophages by means of a novel peptide-drug-conjugate (PDC) which is able to slow tumor progression and supress lung metastasis. Pagination Current page 1 Page 2 Siguiente > Next page Última » Last page Social Media twitter linkedin youtube
Health Diagnostics Imaging Therapy Drug delivery Oncology Engineered gold nanoparticles for enhanced radiotherapy Engineered gold-containing mesoporous silica nanoparticles act as next-generation radioenhancers for cancer radiotherapy. The platform enhances tumour-specific radiation effects while improving nanoparticle biocompatibility, circulation time and tumour acumulation.
Health Diagnostics Imaging Oncology Fluorescent nanovesicles as a bioimaging tool Ultra-bright fluorescent nanoparticles with Near-Infrared emission for non-invasive imaging and diagnostics.
Health Therapy Small Molecule Oncology CCTBloCk, repurposed drugs as breast cancer therapy Two repurposed drugs have been identified that act by inhibiting CCT, an essential chaperone in tumor proteostasis and the folding of key proteins for tumor proliferation, migration, and invasiveness.
Health Therapy Cell Therapy Oncology Copper–Thiourea Anticancer Complexes with Enhanced Potency and Reduced Toxicity Copper complexes with thiourea ligands have demonstrated high cytotoxic activity against tumor cells, along with low toxicity in murine models. Furthermore, these complexes exhibit high stability under physiological conditions.
Health Therapy Oncology Process for increasing the efficiency of magnetic iron oxide nanoparticles in hyperthermia New method that enhances the performance of iron oxide nanoparticles (IONPs), facilitating the implementation of magnetic hyperthermia (MH) therapies.
Health Clinical Application Therapy Oncology In vivo verification of radiation dose delivered in particle therapies System that enables the measurement and verification of the radiation dose received by a patient following proton or helium ion therapy. It uses PET and the natural production of F-18 in tissues, offering applications in oncology and clinical safety.
Health Therapy Peptide / Protein Oncology Agriculture, livestock and marine science Legume derived nutraceuticals as radiosensitizing agents for tumor cells Natural nutraceutical to promote the prevention of the cancer stem cells (CSCs) phenotype acquisition at the origin of tumor regrowth, metastasis and relapse.
Health Medical device Therapy Materials Micro & Nanomaterial Health Oncology Hydrogel for its use in CAR-T Therapy Novel Hydrogel with optimized mechanical and structural properties to resemble artificial lymph nodes and improve primary human CAR-T cell manufacture.
Health Therapy Small Molecule Oncology Novel type of PROTACs directly targeting the proteasome for cancer treatment Design of a novel proteolytic set of chimeras (26STACs) directed at the degradation of the ceramide transfer protein CERT-1 by the proteasome, in an E3-independent manner, for its use in the treatment of breast cancer.
Health Therapy Peptide / Protein Oncology Mactide-V, a peptide-drug-conjugate for efficient treatment of triple-negative breast cancer Effective triple-negative breast cancer treatment based on the modulation of the phenotype of CD206+ tumor associated macrophages by means of a novel peptide-drug-conjugate (PDC) which is able to slow tumor progression and supress lung metastasis.
